EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Insights into the Bioactivities and Mechanism of Action of the Microbial Diketopiperazine Cyclic Dipeptide Cyclo(L-leucyl-L-prolyl)

Christian Bailly iD

Marine Drugs · 09.10.2025 · 23 (10) · 397

DOI: 10.3390/md23100397 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Marine Drugs, online erschienen am 09.10.2025. Verfasst von Christian Bailly. Beteiligte Einrichtung: UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, CHU Lille, CNRS, Inserm, OncoLille Institute, University of Lille,…. Hauptthemen laut MEDLINE: Diketopiperazines, Peptides, Cyclic, Dipeptides, Anti-Infective Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diketopiperazines (DKPs) are biologically important cyclic dipeptides widespread in nature, associated primarily with microorganisms. This is the case for the 2,5-DKP derivative cyclo(L-Leu-L-Pro) (cLP), also known as gancidin W or PPDHMP, identified from a variety of bacteria and fungi, and occasionally found in food products. The present review retraces the discovery of cLP, its identification in living species, its chemical syntheses, and its biochemical properties. In bacteria, cLP is often associated with other DKPs to serve as a defense element against other microorganisms and/or as a regulator of bacterial growth. cLP plays a role in quorum-sensing and functions as an anticariogenic and antifungal agent. The antimicrobial mechanism of action and molecular targets of cLP are evoked. The interest in cLP for combatting certain parasitic diseases, such as malaria, and cancers is discussed. The capacity of cLP to interact with CD151 and to down-regulate the expression of this tetraspanin can be exploited to reduce tumor dissemination and metastases. The review sheds light on the pharmacology and specific properties of cyclo(L-Leu-L-Pro), which can be useful for the development of a novel therapeutic approach for different human pathologies. It is also of interest to help define the bioactivity and mechanisms of action of closely related DKP-based natural products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiketopiperazinesPeptides, CyclicDipeptidesAnti-Infective AgentsHumansAnimalsBacteriaQuorum SensingAntineoplastic Agents

Stichwörter der Autor:innen

cyclo(Leu-Pro)diketopiperazinegancidinmechanism of actionmicroorganisms

Substanzen

DiketopiperazinesPeptides, CyclicDipeptidesAnti-Infective AgentsAntineoplastic Agents

Autor:innen und Institutionen

  • UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, CHU Lille, CNRS, Inserm, OncoLille Institute, University of Lille, 59000 Lille, France.
  • Institute of Pharmaceutical Chemistry Albert Lespagnol (ICPAL), Faculty of Pharmacy, University of Lille, 59006 Lille, France.
  • OncoWitan, 59290 Lille, France.

ORCID-Profile: Christian Bailly

Zitieren

APA

Bailly, C. (2025). Insights into the Bioactivities and Mechanism of Action of the Microbial Diketopiperazine Cyclic Dipeptide Cyclo(L-leucyl-L-prolyl). Marine Drugs, 23(10), 397. https://doi.org/10.3390/md23100397

Vancouver

Bailly C. Insights into the Bioactivities and Mechanism of Action of the Microbial Diketopiperazine Cyclic Dipeptide Cyclo(L-leucyl-L-prolyl). Marine Drugs. 2025;23(10):397. doi:10.3390/md23100397

BibTeX
@article{Bailly2025,
  author = {Bailly, Christian},
  title = {Insights into the Bioactivities and Mechanism of Action of the Microbial Diketopiperazine Cyclic Dipeptide Cyclo(L-leucyl-L-prolyl)},
  journal = {Marine Drugs},
  year = {2025},
  volume = {23},
  number = {10},
  pages = {397},
  doi = {10.3390/md23100397}
}
Kostenlos starten →